淋巴水肿治疗的研究进展

淋巴水肿是淋巴系统的一种慢性疾病。随着我国恶性肿瘤发病人数和发病率的增加,癌症治疗后的淋巴水肿已经成为继发性淋巴水肿的主要病因。正确、合理的治疗对淋巴水肿预后十分重要。近年来,淋巴领域的治疗进展给患者带来了新的希望。本文就淋巴水肿治疗的研究进展进行综述。     

虚拟现实技术在医学教育中的应用价值

随着计算机、网络和信息技术的飞速发展,虚拟现实技术应运而生,并在医学教育领域中广泛应用.目前国外开展了虚拟解剖学、虚拟放射学及虚拟内窥镜学等计算机辅助教学,国内开展了数字化可视人体研究,建立了现代化模拟医院,进行急诊医学高仿真模拟教学,构建了医学检验虚拟实验室和虚拟实验教学系统等.虚拟现实技术在医学教育中的应用充实了理论知识的学习,弥补了实验教学资源的不足,优化升级软件、节省教育资源,模拟真实情境避免各种危险,突破时空限制,为医学教育事业的发展发挥了积极的推动作用.     

Effects of Tick-Control Interventions on Tick Abundance,Human Encounters with Ticks,and Incidence of Tickborne Diseases in Residential Neighborhoods,New York,USA

Tickborne diseases (TBDs) such as Lyme disease result in ≈500,000 diagnoses annually in the United States. Various methods can reduce the abundance of ticks at small spatial scales, but whether these methods lower incidence of TBDs is poorly understood. We conducted a randomized, replicated, fully crossed, placebo-controlled, masked experiment to test whether 2 environmentally safe interventions, the Tick Control System (TCS) and Met52 fungal spray, used separately or together, affected risk for and incidence of TBDs in humans and pets in 24 residential neighborhoods. All participating properties in a neighborhood received the same treatment. TCS was associated with fewer questing ticks and fewer ticks feeding on rodents. The interventions did not result in a significant difference in incidence of human TBDs but did significantly reduce incidence in pets. Our study is consistent with previous evidence suggesting that reducing tick abundance in residential areas might not reduce incidence of TBDs in humans.     

复发性阿弗他溃疡心理因素生物标志物研究进展

复发性阿弗他溃疡(recurrent aphthous ulcer,RAU)是一种口腔黏膜常见的炎症性溃疡类疾病.据调查,人群中RAU的发病率高,且溃疡发作时灼痛明显,尤其是重型复发性阿弗他溃疡(major recurrent aphthous ulcer,MaRAU)发作时疼痛剧烈,严重影响着人们的日常工作和生活.R...     

重症肌无力中医治疗进展

从病因病机(经络论证、脏腑论证)、治疗(汤剂、固定组方、针灸)论述中医治疗重症肌无力。认为,应规范临床科研优选最佳科研方案,建立统一的疗效评定标准。     

妇科恶性肿瘤的时辰化疗进展

目的介绍近年来适用于妇科恶性肿瘤化疗的药物涉及时辰方案设计的研究成果,方法通过搜集并整理近年来国内外时辰化疗的相关临床和临床前试验的相关文献结果与结论应用时辰化疗理论,改进妇科肿瘤患者化疗方案和给药时间,可以有效降低化疗药物的毒副作用,较常规治疗具有优势,但不同人群、不同种族间的时辰依赖性是否存在差异,有待于进一步研究、     

高选择性环氧化酶—2抑制剂的进展与评价

目的 :介绍高选择性环氧化酶 - 2抑制剂———昔布类药物进展 ,并评价其临床疗效 ,以供临床参考。方法 :查阅国内、外近期相关文献进行分析、评价。结果与结论 :昔布类高选择性环氧化酶 - 2抑制剂进展十分迅速 ,对环氧化酶 - 2的选择性高 ,在治疗骨关节炎和类风湿性关节炎、关节痛、术后疼痛和肿瘤上展现了良好的治疗前景     

“Heart failure in COVID-19 patients: Critical care experience”: A letter to the editor

Coronavirus disease 2019 (COVID-19) is associated with poor cardiovascular outcomes in patients with heart failure (HF) of all categories of ejection fraction (EF), but mainly in patients with HF with reduced EF. Moreover, cardiac transplant patients exhibit worse cardiovascular prognosis, high mortality, and more admissions to the intensive care unit. In general, COVID-19 seems to de-teriorate the clinical status of HF and favors the development of acute respiratory distress syndrome and multiorgan failure, especially in the presence of cardiovascular comorbidities such as diabetes mellitus, kidney dysfunction, and older age. COVID-19 may induce new-onset HF with complex mechanisms that involve myocardial injury. Indeed, myocardial injury comprises a large category of detrimental effects for the myocardium, such as myocardial infarction type 1 or type 2, Takotsubo cardiomyopathy, microvascular dysfunction and myocarditis, which are not easily distinguished by HF. The pathophysiologic mechanisms mainly involve direct myocardial damage by severe acute respiratory syndrome coronavirus 2, cytokine storm, hypercoagulation, inflammation, and endothelial dysfunction. The proper management of patients with COVID-19 involves careful patient evaluation and ongoing monitoring for complications such as HF.     

实验室信息管理系统的技术与应用进展

实验室信息管理系统(LIMS)自问世以来,在世界范围内取得了令人惊叹的技术进展和应用成就。该文从现代化实验室实施LIMS的意义,LIMS主要的技术发展阶段,目前国内LIMS的应用情况,分析测试性实验室在实施LIMS后预期达到的目标,以及当前LIMS项目实施中存在的问题和应用前景等方面进行综述。